News Story: Full Text
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website

 

Highlights from the Society for Neuro Oncology annual meeting, San Francisco California, November 16-19 2017

Al's Comment:

 Our medical editor, Stephen Western, put together what we feel are the most important stories from the SNO meeting!  

There are a few reports of long term survivors with no recurrence after a few years - with Optune, Toca 511, and a new vaccine.  If it were possible to combine these things, we may have something that is effective for the majority of patients!  We are working on that - stay tuned!

 


Posted on: 12/23/2017

Highlights from the Society for Neuro Oncology annual meeting, San Francisco California, November 16-19 2017 

Click : https://virtualtrials.com/SNO_2017_Clinical_Highlights_treatments.cfm

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites



Musella Foundation For Brain Tumor Research & Information, Inc